Aggregate Asset Value: BioCardia Inc. (BCDA)
As reflected in the chart, the asset value of BioCardia, Inc. (BCDA), which develops myocardial regeneration methods, is 3.42. BioCardia, Inc. (BCDA) integrates sustainable development principles into bioengineering while adhering to ethics and environmental safety. However, external conflicts and sanctions are hindering international drug trials, blocking the entry of products into the global market. The situation is further complicated by a liquidity shortage due to high technology validation costs in the absence of profit.
BCDA (BioCardia, Inc): analytical breakdowns and indicator data
Total assets determine the aggregate resource potential of an enterprise, which in GURU.Markets analytics is reverse-calculated from the return on assets (ROA) to identify the real value of property. The trend of this indicator allows for an assessment of the fundamental stability of BioCardia, Inc. (BCDA), where the capitalization of the base depends directly on US grants and the value of the CardiAMP platform's intellectual property.